Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000031.xml
Download PDF
Klin Monbl Augenheilkd 2003; 220(8): 526-531
DOI: 10.1055/s-2003-41871
DOI: 10.1055/s-2003-41871
Übersicht
© Georg Thieme Verlag Stuttgart · New YorkDie diabetische Makulopathie - Klinik und Therapie
Diabetic Maculopathy - Classification and TherapyGefördert durch DFG Jo 324/4-1, Jo 324/6-1, ZMMK Köln (TV76), Ernst und Berta Grimmke Stiftung und Gertrud und Werner Müller StiftungFurther Information
Publication History
Eingegangen: 10. Juni 2003
Angenommen: 14. Juli 2003
Publication Date:
03 September 2003 (online)
Zusammenfassung
Im Hinblick auf die Therapie der Makulopathie scheint die derzeit gängige klinische Einteilung in die fokale, diffuse und ischämische Makulopathie sinnvoll. Die vorliegende Zusammenfassung diskutiert den Einsatz therapeutischer Standardverfahren sowie der in jüngster Zeit zunehmenden chirurgischen und pharmakologischen Möglichkeiten.
Abstract
The current clinical classification into focal, diffuse, and ischaemic maculopathy is useful with respect to pathomechanism and therapy. This review discusses the value of standard therapeutical options as well as the recent surgical and pharmacological approaches.
Schlüsselwörter
Diabetische Retinopathie - diabetische Makulopathie - klinische Einteilung - Lasertherapie - ILM-Peeling - Triamcinolon
Key words
Diabetic retinopathy - diabetic maculopathy - clinical classification - laser therapy - ILM peeling - triamcinolone
Literatur
- 1 Aiello L M, Ferris F L. Photocoagulation for diabetic macular edema. Arch Ophthalmol. 1987; 105 1163
- 2 Akduman L, Olk R J. Laser photocoagulation of diabetic macular edema. Ophthalmic Surg Lasers. 1997; 28 387-408
- 3 Antonetti D A, Wolpert E B, DeMaio L, Harhaj N S, Scaduto R C. Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J Neurochem. 2002; 80 667-677
- 4 Bailey C C, Sparrow J M, Grey R H, Cheng H. The National Diabetic Retinopathy Laser Treatment Audit. III. Clinical outcomes. Eye. 1999; 13 151-159
- 5 Bertram B, Arens C DH.
Leitlinie Nr. 20: Diabetische Retinopathie. In: Bertram B, Arens CDM (Hrsg) Praxisorientierte Handlungsleitlinien für Diagnose und Therapie in der Augenheilkunde. Düsseldorf; Berufsverband der Augenärzte Deutschlands 1998MissingFormLabel - 6 Blankenship G W. Diabetic macular edema and argon laser photocoagulation: a prospective randomized study. Ophthalmology. 1979; 86 69-78
- 7 Bresnick G H, Venecia G de, Myers F L, Harris J A, Davis M D. Retinal ischemia in diabetic retinopathy. Arch Ophthalmol. 1975; 93 1300-1310
- 8 Bresnick G H. Diabetic macular edema. A review. Ophthalmology. 1986; 93 989-997
- 9 Bresnick G H. Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology. 1983; 90 1301-1317
- 10 Caird F I, Hutchinson M, Pirie A. Cataract extraction and diabetes. Br J Ophthalmol. 1965; 49 466-471
- 11 Cardillo Piccolino F, Zingirian M, Mosci C. Classification of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 1987; 225 245-250
- 12 Early Treatment Diabetic Retinopathy Study Research Group . Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology. 1991; 98 766-785
- 13 Fong D S, Segal P P, Myers F, Ferris F L, Hubbard L D, Davis M D. Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol. 1997; 115 873-877
- 14 Gandorfer A, Messmer E M, Ulbig M W, Kampik A. Resolution of diabetic macular edema after surgical removal of posterior hyaloid and the inner limiting membrane. Retina. 2000; 20 126-133
- 15 Garner A. Histopathology of diabetic retinopathy in man. Eye. 1993; 7 250-253
- 16 Global Diabetic Retinopathy Project Group .International clinical diabetic macular edema disease severity scale. 2002
MissingFormLabel
- 17 Grey R H. The treatment of diabetic maculopathy by argon laser photocoagulation. Trans Ophthalmol Soc U K. 1986; 105 424-429
- 18 Hammes H P, Bertram B, Bornfeld N, Gandjour A, Parandeh-Shab F, Danne D, Kroll P, Lemmen K D, Look D.
Diagnostik, Therapie und Verlaufskontrolle der diabetischen Retinopathie und Makulopathie. In: Scherbaum WA, Lauterbach KW, Renner R (Hrsg) Evidenzbasierte Diabetes-Leitlinien DDG. 1. Auflage. Deutsche Diabetes-Gesellschaft 2000MissingFormLabel - 19 The Diabetic Retinopathy Study Research Group . Indications for photocoagulation treatment of diabetic retinopathy: Diabetic Retinopathy Study Report no. 14. Int Ophthalmol Clin. 1987; 27 239-253
- 20 Isenberg S J, Apt L, Yoshimori R, Khwarg S. Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic. Arch Ophthalmol. 1985; 103 1340-1342
- 21 Jaffe G J, Burton T C. Progression of nonproliferative diabetic retinopathy following cataract extraction. Arch Ophthalmol. 1988; 106 745-749
- 22 Jonas J B, Kreissig I, Sofker A, Degenring R F. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol. 2003; 121 57-61
- 23 Jonas J B, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol. 2001; 132 425-427
- 24 Kadonosono K, Itoh N, Ohno S. Perifoveal microcirculation before and after vitrectomy for diabetic cystoid macular edema. Am J Ophthalmol. 2000; 130 740-744
- 25 Klein R, Klein B E, Moss S E, Davis M D, DeMets D L. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology. 1984; 91 1464-1474
- 26 Klein R, Klein B E, Moss S E. Visual impairment in diabetes. Ophthalmology. 1984; 91 1-9
- 27 Ladas I D, Theodossiadis G P. Long-term effectiveness of modified grid laser photocoagulation for diffuse diabetic macular edema. Acta Ophthalmol (Copenh). 1993; 71 393-397
- 28 Lee C M, Olk R J. Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results. Ophthalmology. 1991; 98 1594-1602
- 29 Lemmen K D, Ulbig M W, Bornfeld N, Bertram B, Gerke E H. Initiativgruppe Früherkennung diabetischer Augenerkrankungen: Stadieneinteilung und
Therapie der diabetischen Retinopathie und Makulopathie, Report No. 3. Heidelberg; Kaden 2001
MissingFormLabel
- 30 Martidis A, Duker J S, Greenberg P B, Rogers A H, Puliafito C A, Reichel E. et al . Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 2002; 109 920-927
- 31 McDonald H R, Schatz H. Macular edema following panretinal photocoagulation. Retina. 1985; 5 5-10
- 32 McNaught E I, Foulds W S, Allan D. Grid photocoagulation improves reading ability in diffuse diabetic macular oedema. Eye. 1988; 2 288-296
- 33 Meyers S M. Macular edema after scatter laser photocoagulation for proliferative diabetic retinopathy. Am J Ophthalmol. 1980; 90 210-216
- 34 Olk R J. Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema. Ophthalmology. 1990; 97 1101-1112; discussion 1112 - 1113
- 35 Olk R J. Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema. Ophthalmology. 1986; 93 938-950
- 36 Early Treatment Diabetic Retinopathy Study research group . Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol. 1985; 103 1796-1806
- 37 Early Treatment Diabetic Retinopathy Study Research Group . Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study Report no. 4. Int Ophthalmol Clin. 1987; 27 265-272
- 38 Schatz H, Atienza D, McDonald H R, Johnson R N. Severe diabetic retinopathy after cataract surgery. Am J Ophthalmol. 1994; 117 314-321
- 39 Schatz H, Madeira D, McDonald H R, Johnson R N. Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. Arch Ophthalmol. 1991; 109 1549-1551
- 40 Straatsma B R, Pettit T H, Wheeler N, Miyamasu W. Diabetes mellitus and intraocular lens implantation. Ophthalmology. 1983; 90 336-343
- 41 Tachi N, Ogino N. Long-term follow-up of grid photocoagulation for diffuse macular edema associated with diabetic retinopathy. Folia Ophthalmol Jpn. 1996; 47 1252-1256
- 42 Ballegooie E van, Everdingen J J van. CBO guidelines on diagnosis, treatment, and prevention of complication in diabetes mellitus: retinopathy, foot ulcers, nephropathy and cardiovascular diseases. Dutch Institute for Quality Assurance. Ned Tijdschr Geneeskd. 2000; 144 413-418
- 43 Wallow I H. Repair of the pigment epithelial barrier following photocoagulation. Arch Ophthalmol. 1984; 102 126-135
- 44 Watanabe M, Oshima Y, Emi K. Optical cross-sectional observation of resolved diabetic macular edema associated with vitreomacular separation. Am J Ophthalmol. 2000; 129 264-267
- 45 Weiter J J, Zuckerman R. The influence of the photoreceptor-RPE complex on the inner retina. An explanation for the beneficial effects of photocoagulation. Ophthalmology. 1980; 87 1133-1139
- 46 Whitelocke R A, Kearns M, Blach R K, Hamilton A M. The diabetic maculopathies. Trans Ophthalmol Soc U K. 1979; 99 314-320
- 47 Zander E, Herfurth S, Bohl B, Heinke P, Herrmann U, Kohnert K D. et al . Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factors. Br J Ophthalmol. 2000; 84 871-876
PD Dr. Antonia M. Joussen
Abteilung für Netzhaut- und Glaskörperchirurgie · Zentrum für Augenheilkunde
Joseph-Stelzmann-Straße 9
50931 Köln
Email: JoussenA@aol.com
URL: http://www.retina-cologne.de